Determining the feasibility and efficacy of Goal Management Training for improving treatment retention and outcomes during residential treatment for methamphetamine dependence
Investigator: Prof Antonio Verdejo-Garcia, Eric Allan, and Prof Dan Lubman
This project brings together a team of experts in addiction neuroscience, MARC members Prof Verdejo-Garcia and Prof Lubman, and frontline clinician, Eric Allan, to examine whether Goal Management Training (GMT) is feasible and well accepted by methamphetamine users in Australian public treatment and rehabilitation centres, and if it reduces relapse rates after treatment discharge. They will conduct an exploratory randomised controlled trial to test the feasibility/ acceptability and preliminary efficacy of a 4-week GMT protocol versus a control psychoeducation intervention. They have developed the 4-week GMT protocol (which is shorter and contains more tailored materials than standard GMT) to cater the specific needs of methamphetamine users (e.g. making long-term [vs reward] based decisions). The primary outcomes will be proportion of GMT completions; participants’ assessments of acceptability, engagement and benefit; and rates of abstinence four weeks post-discharge measured with hair toxicology. The findings of this study will be readily translated into standard practice.
Project funders
National Centre for Clinical Research on Emerging Drugs (NCCRED)
Project partners
A collaboration between Turner Institute for Brain and Mental Health, Turning Point and MARC
Publications
Anderson, AC, Robinson, AH, Potter, E, Kerley, B, Flynn, D, Lubman DI, Verdejo-Garcia, A. (2021). Development of Goal Management Training+ (GMT+) for Methamphetamine Use Disorder through collaborative design: A process description. medRxiv 2021.08.01.21261454. DOI:10.1101/2021.08.01.21261454
Anderson, AC, Youssef, GJ, Robinson, AH, Lubman, DI & Verdejo-Garcia, A. (2021). Cognitive boosting interventions for impulsivity in addiction: a systematic review and meta-analysis of cognitive training, remediation and pharmacological enhancement. Addiction. DOI: 10.1111/add.15469